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Abstract
Objective: Nuclear factor kappa B (NF-κB) pathway and oxidative 
stress participate in endothelial dysfunction, which is one of the 
causes of preeclampsia. Among the human antioxidant mechanisms 
there are the enzymes catalase (CAT), glutathione peroxidase (GPx) 
and superoxide dismutase (SOD). Our aim was to measure NF-κB, 
its inhibitor (IKK) and oxidative stress in placenta and umbilical 
cord of pregnant women submitted to a supervised nutritional 
program. 
Methods: Two groups were conformed: A) 14 pregnant women 
with individualized nutritional counseling and B) 12 pregnant 
women without nutritional guidance. NF-κB and IKK were 
assessed by real time PCR (RT-PCR). Enzymatic activity of CAT, 
GPx, lipoperoxidation (LPO) and SOD were also evaluated.
Results: Pregnant women that followed-up a supervised nutritional 
program had lower level of systolic (p=0.03) and diastolic pressure 
(p=0.043) although they were heavier than a control group 
(p=0.048). Among all women, the Spearman correlation was 
positive between weight gain and placental NF-κB expression (1, 
p≤0.01). In placenta, women with nutritional advice had lower 
enzymatic activity of GPx (p≤0.038) and showed a tendency of 
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IKK to be higher than in women without a nutritional supervised 
program. 
Conclusion: A supervised nutritional program in pregnancy offers 
a proven option to control weight gain, hypertension, NF-κB/IKK 
complex expression and oxidative stress reactions in placenta.
Keywords: Diet; NF-κB; Oxidative stress; Pre-eclampsia; 
Pregnancy.
Introduction
Obesity during pregnancy is associated with exaggerated 
metabolic adaptation, endothelial dysfunction and an increased 
risk of adverse pregnancy outcomes, including pre-eclampsia,1 
hypertension and gestational diabetes mellitus (GDM).2 Pre-
eclampsia is a major cause of maternal and fetal morbidity and 
mortality that affects approximately 3% to 7% of all pregnant 
women.3
Nuclear factor-kappa B (NF-κB), a heterodimer located in 
the cytoplasm, is bound by its inhibitor κB (IκB), which prevents 
NF-κB from entering the nucleus.4 It has been attributed to NF-
κB the activation of a systemic inflammatory process demonstrated 
in plasma from preeclamptic women, by promoting the synthesis 
of cytokines, interleukin (IL)-6, IL-8, monocyte chemotactic 
protein-1 (MCP-1) and expression of intercellular adhesion 
molecule (ICAM-1).5
There is current evidence that NF-κB is activated by reactive 
oxygen species (ROS) [superoxide anions (•O2
-), hydrogen peroxide 
(H2O2) and hydroxyl radicals (•OH)].
6 Besides, ROS interact 
with proteins, nucleic acids and lipids and in a process called lipid 
peroxidation (LPO), that can cause severe cell and tissue damage.7,8
To maintain balance of the oxidative state, the human body 
possesses intracellular antioxidant enzyme systems, including 
catalase (CAT), five different forms of glutathione peroxidase 
(GPx) and three isoforms of superoxide dismutase (SOD).9 Under 
physiological conditions, these defense mechanisms maintain a 
low concentration of ROS within the cell and regulate its activity. 
Thus, a balance between ROS production and antioxidant defenses 
determines the degree of oxidative stress.10
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The role of maternal diet in the etiology of pre-eclampsia 
has received increasing attention.11 Based on the epidemiology of 
pre-eclampsia, which is more common among poor women, had 
previously suggested that nutrients may be involved in the disorder, 
unfortunately, the nutritional data obtained from women with the 
syndrome has been poorly defined.12
A current theory holds that an imbalance between maternal 
pro- and anti-oxidants, is a component of pre-eclampsia.13 It still 
remains unknown whether such an imbalance occurs prior to 
clinical recognition of the syndrome or whether it is related to diet; 
however, maternal diet is a known, underlying environmental factor 
that contributes to free radical generation.14
The objective of this paper was to measure NF-κB, its inhibitor 
subunit beta (IKKB), and oxidative stress in placenta and umbilical 
cord of pregnant women submitted to a supervised nutritional 
program, in order to provide a possible explanation of the benefits 
when limiting gestational weight gain.
Methods
This clinical, prospective and comparative study was carried out in 
Toluca, Mexico, during March 2009 to December 2010.
Pregnant women aged 18-40 y in the first trimester of pregnancy, 
attended at the Maternal-Perinatal Hospital "Mónica Pretelini" 
(HMPMP), Toluca, Mexico, were considered for the study. Subjects 
with multiple pregnancies or prior history of chronic-metabolic 
diseases including GDM or pre-pregnancy hypertension were 
excluded. Those women with incomplete medical records, who did 
not deliver at the hospital or attended less than two nutritional visits 
during the pregnancy, were considered lost to the study.
Two study groups were done: A) women who were offered an 
individualized diet and B) women attending the obstetrics unit who 
did not follow a supervised diet. Initially we assigned 20 pregnant 
women to each group (actually, 13 were enough to recognize as 
statistically significant difference3 2 relative units of NF-κB, with α 
risk of 0.05 and a ß risk of 0.2 in a two-sided test, with a standard 
deviation (SD) of 1.7 and a drop-out rate of 10%),15 from whom 14 
completed the nutritional supervision and 12 the control group (one 
patient did not come back, nine deliveries were attended in other 
hospitals and four were discarded because samples were not well 
preserved).
All women who sought medical attention at the high-risk 
pregnancy clinic of the HMPMP were offered the opportunity to 
be included in the study. After the acceptance of one mother to be 
nutritionally supervised, we captured one control woman in the Red 
Code Service with the most proximal age to the case. If this woman 
was lost in the follow-up period we captured another woman in the 
previous service without age criteria due to time limitations (nine 
months of pregnancy).
Anthropometric measures were assessed in the high-risk 
pregnancy clinic by HMPMP nutritionist. Body weight was 
measured in an overnight fasting status without shoes in a minimal 
clothing state by the use of a digital scale (Seca, Hamburg, 
Germany) to the nearest 0.1 kg. Height was measured using a non-
stretched tape measure (Seca, Hamburg, Germany) to the nearest 
0.1 cm. Pre-pregnancy BMI was calculated as weight in kg divided 
by height in meters squared based on the prenatal chart or self-
reported weight in women with no prenatal chart, since previous 
studies have ratified its suitability.16
Blood pressure was recorded at each visit using a standard 
sphygmomanometer (Riester Big Ben® Square, Germany) and 
appropriately sized cuff, that was changed to an electronic monitor 
(Mercury, Mennem Medical, USA) if a case was confirmed as 
preeclampsia.
Fasting blood samples (10 mL) were taken at the HMPMP 
laboratory in an early morning after an overnight fast. Serum 
samples were analyzed for serum albumin, calcium, cholesterol, 
creatinine, magnesium, triglycerides and uric acid using appropriate 
kits (Dimension Rx L Max, Dade Behring, USA). Serum 
hemoglobin using available kits (Advia 120, Bayer Health, USA) 
were measured. Fasting plasma glucose (FPG) was assayed with 
available kits (Dimension Rx L Max, Dade Behring, USA).
Dietetic treatment was calculated according to height, weeks of 
gestation and weight, considering an energy intake of 30 kcal/kg of 
expected weight, distributing the resulting energy according to the 
percentage of macronutrients’ adequation (55-65% carbohydrates, 
10-20% fat and the remainder as proteins).17 On each nutritional 
visit, 24 hour dietary recall was done and analysed using 
NutriKcal®VO software in order to evaluate the Healthy Eating 
Index (HEI), which is commonly employed to assess pregnant 
women’s dietary adequacy (on a scale from 0-100), through 
the consumption of 12 components of food groups described 
previously.18,19 An improvement in diet was considered when the 
initial HEI score improved more than one point during the next 
nutritional assessment.
Pre-eclampsia was diagnosed and classified according to the 
criteria specified by the technical bulletin of the American College 
of Obstetricians and Gynecologists (ACOG) and the National 
High Blood Pressure Education Program (NHBPEP) Working 
Group Report on High Blood Pressure in Pregnancy.20
During pregnancy resolution, a sample of placenta and umbilical 
cord in heparinized vials were kept at -80°C (Forma -86ºC ULT 
Freezer, Thermo Electron Corporation, USA) until use.
One sample of each tissue from all mothers was weighed 
(Ohaus Trip Balance), prepared in buffer under sterile conditions 
(Forma Laminar Airflow Workstation, Thermo Scientific), heated 
( J18 Bain Univ, Jouan) and centrifuged (IEC CL40R Centrifuge, 
Thermo Scientific).
mRNA was isolated using the Magna Pure LC RNA Isolation 
Kit III and retro-transcribed with the Transcriptor High Fidelity 
cDNA Synthesis Kit (Roche) to obtain cDNA. Samples were 
then quantified using a nano spectrophotometer set (Nano 
Photometer, Implen) at two wavelengths (260 nm and 280 nm), 
with an acceptable degree of purity between 1.8 and 2 for real 
time reverse transcriptase polymerase chain reaction (RT-PCR) 
performed in a Roche LightCycler 2.0 using the SYBR® Advantage® 
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qPCR Premix Kit following the manufacturer’s instructions. 
The steps were: denaturation, alignment and elongation. Primer 
sequences (determined with Primer 3 software) were as follows: 
NF-κB (NCBI: NM_003998.3), fw: 5’-cctggatgactcttgggaaa-3’, 
rv: 5’-tcagccagctgtttcatgtc-3’ and IKKB (NCBI: NM_001556.1), 
fw: 5’-gctgcaactgatgctgatgt-3’, rv: 5’-tgtcacagggtaggtgtgga-3’. The 
relative expression of each gene, compared to expression of the beta-
2 microglobulin (B2M) gene (NCBI: NM_004048.2) (control) 
using fw: 5’-ttcatccstccgacattgaa-3’ and rv: 5’-cctccatgatgctgcttaca-3’ 
was calculated through the method 2−ΔΔCT.
RT-PCR products were performed at the Laboratory of 
Molecular Biology, Medical Research Center (CICMED), 
Autonomous University of the State of Mexico (UAEMex) and 
sequenced and read with Chromas software v. 2.33 (Instituto 
de Neurobiología, National Autonomous University of Mexico, 
UNAM), to verify the correct amplification of the primers.
Tissue (1 g) was added into 4 mL of Phosphate Buffer Solution 
(PBS) (pH 7.4) and homogenized (Tissue Tearor™, Biospec 
Products, Inc.). The supernatant was then centrifuged at 2000 rpm 
for 5 min and then at 9000 rpm for 15 min. Next, it was sonicated for 
30 min and then submitted to a final centrifugation step at 13,500 
rpm for 30 min. The entire process was conducted at -4ºC and the 
supernatant was removed and used for different determinations.
CAT activity (μmol H2O2/mg protein) was determined 
according to the technique described by Radi et al.21 GPx activity 
(nmol NADPH/mg protein) was quantified by the Paglia 
and Valentine method.22 LPO (nmol MAD/mg protein) was 
determined using the Büege and Aust method.23 SOD activity 
(mmol/mg protein) was analysed according to the Misra and 
Fridovich modified method.24
Protein concentration was spectrophotometrically determined 
using the Bradford protein assay.25 To 25 μL of supernatant, 75 
μL deionized water and 2.5 mL of Bradford’s reagent (100 mg 
Coomassie Blue dye, 50 mL 95% ethanol and 100 mL H3PO4, in 
1 L deionized water) were added. Tubes were shaken and allowed 
to rest for 5 min prior to reading the absorbance at 595 nm and 
interpolation using a bovine serum albumin standard curve. 
Enzymatic and protein quantification were performed at the Faculty 
of Chemistry, UAEMex.
Written consent was obtained from all subjects. This study 
was approved by the Bioethics and Research Committee of the 
HMPMP, date code 05/06/09.
Statistical analysis of the data was carried out using SPSS 
version 17. Continuous variables were expressed as mean ± SD. As 
there was no normal distribution, we compared the groups using 
the Mann-Whitney U-test. The degree of association between the 
biomarkers of oxidative stress with gene expression was evaluated 
using Spearman’s correlation; p < 0.05 was considered statistically 
significant.
Results
Table 1 lists the results of maternal characteristics of the study 
population. In women receiving nutritional advice, from whom 




(n = 14) 95% CI
Whithout nutritional advise
(n = 12) 95% CI
p2
Maternal age (years) 27.7 + 5.3 [24.9-30.5] 26.7 + 6.1 [23.2-30.1] 0.796
Gestational age (weeks)┼** 39.8 + 0.6 [39.5-40.2] 38.1 + 1.5 [37.2-39] 0.007
Parity 0.9 + 1.1 [1.3-2.8] 0.7 + 1.2 [1-2.4] 0.485
Pre-pregnancy weight (kg)* 73.2 + 8.3 [68.8-77.6] 64 + 11.1 [57.7-70.3] 0.048
Height (m) 1.57 [1.54-1.61] 1.58 [1.56-1.60] 0.625
Pre-pregnancy BMI (kg/m2)* 29.5 + 2.6 [28.2-31] 25.5 + 3.9 [23.4-27.8] 0.019
Final weight (kg) 82.2 + 9.7 [77.1-87.4] 74.7 + 12.5 [67.6-81.8] 0.154
Final BMI (kg/m2) 33.2 + 2.7 [31.7-34.6] 29.8 + 4.3 [27.3-32.2] 0.122
Weight gain (kg) 9 + 4.5 [6.7-11.4] 10.7 + 3.8 [8.5 -12.9] 0.192
Systolic blood pressure (mmHg)* 127.7 + 18.5 [118-137] 149.3 + 23.6 [135-162] 0.030
Diastolic blood pressure (mmHg)* 79.3 + 12.6 [72-86] 91.6 + 13.7 [83-99] 0.043
Mean blood pressure (mmHg)* 95.5 + 14.1 [88-102] 110.8 + 16.1 [101-120] 0.013
FPG (mg/dl) 77 + 11.5 [71-83.1] 76.3 + 9.6 [70.8-81.8] 0.842
Cholesterol (mg/dl) 221.8 + 39.3 [201-242] 199 + 44.3 [173-224] 0.388
Tryglicerides (mg/dl) 255.3 + 102.9 [201-309] 311.6 + 119.9 [243-379] 0.529
Hemoglobin (g/dl) 14.1 + 0.7 [13.7-14.6] 13 + 2.1 [11.8-14.3] 0.235
Creatinine (mg/dl) 0.7 + 0.1 [0.6-0.7] 0.6 + 0.1 [0.6-0.7] 0.460
1 Data are means ± standard deviation; 2 Obtained from independent Mann-Whitney U-test; 3 Fasting plasma glucose
┼: weeks of pregnancy from the last menstrual period. CI: confidence interval.
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nine (64.2%) had an improvement in the quality of the diet, 
statistically significant differences were seen in weeks of gestation 
(weeks of pregnancy from the start of the last normal menstrual 
period) (longer, p≤0.01), pre-pregnancy weight and pre-pregnancy 
BMI (p≤0.05). At the end of their gestational period, women in 
the group without nutritional advice had higher systolic, diastolic 
and median hypertension levels (p≤0.05).Six women (42.8%) from 
group A (with individualized diets) had pregestational obesity (pre-
pregnancy BMI 3 30 kg/m2) and two women (14.2%) from this 
group developed pre-eclampsia. Unsurprisingly, these patients had 
the second and third highest weight gain (12 and 11 kg), which were 
2-3 kg above the median (9 kg). Eight women (57.1%) from this 
group were pregestationally overweight (25 < pre-pregnancy BMI 
≤30) and none of them had a normal pre-pregnancy BMI (<25).
From group B (no diet supervision), only one woman (8.3%) 
had pre-gestational obesity, and three (25%) were overweight. A 
total of six women from this group developed pre-eclampsia, which 
included the individuals with the first and third highest weight gain.
In placenta, IKK showed a tendency to be higher in pregnancies 
followed-up with a supervised diet (Figure 1). Notwithstanding, 
this tendency did not reach a statistically significant difference 
(p=0.32). NF-κB showed no significant differences between 
groups. In umbilical cord NF-κB was poorly detected attributed to 
its rich content in Wharton's jelly and IKK did not have significant 
differences.
Figure 1: In plaventa, IKK showed a tendancy to be higher in 
pregnancies.
There were no differences in CAT, LPO and SOD activity. 
Furthermore, there was no difference with the oxidant/antioxidant 
status formula: SOD/(CAT+GPx). Only a statistically significant 
difference in GPx enzymatic activity in placenta was observed 
(p≤0.05), with higher values in the group without nutritional advice 
(Table 2).
Among all women, the Spearman correlation was positive 
between pre-pregnancy weight and final weight (0.934, p≤0.001) 
and between pre-pregnancy BMI and final weight (0.663, p=0.001); 
with placental values this correlation was positive between pre-
pregnancy BMI and SOD (0.341, p=0.018), between weight gain 
and NF-κB (1, p≤0.001), between CAT and GPx (0.634,p≤0.001) 
and negative between LPO and IKK (-0.603, p=0.013).
Significant positive intra-group correlations in those women 
that completed the nutritional supervision were found between pre-
pregnancy weight and BMI (0.739, p=0.003), final weight (0.884, 
p≤0.001), final BMI (0.657, p=0.011) and history of cesareans 
(0.582, p=0.037), between BMI and history of pregnancies (0.633, 
p=0.020) and cesareans (0.838, p=0.001) and final BMI (0.825, 
p≤0.001), between umbilical cord determinations of LPO and GPx 
(0.955), H2O2 (0.925) and SOD (0.999) all three with p≤0.001. 
On the other hand, negative correlations were found between 
placental IKK and hemoglobin (-0.845, p=0.034).
Finally, in the group without nutritional advice, significant 
correlations were found between age and final BMI (0.645, 
p=0.044), between weeks of pregnancy and cholesterol (0.960, 
p=0.002), between pre-pregnancy weight and BMI (0.949, 
p=0.003), final weight (0.954, p≤0.001) and final BMI (0.911, 
p≤0.001), between BMI and final weight (0.882, p=0.001) and final 
BMI (0.943, p≤0.001), between triglycerides and GPx (in placenta 
0.948, p=0.014, in umbilical cord 0.980, p=0.003) and H2O2 (in 
placenta 0.941, p=0.017, in umbilical cord 0.959, p=0.01), between 
placental GPx and umbilical cord GPx (0.953) and H2O2 (0.940) 
both with p≤0.001.
As dependent variable, placental H2O2 reached statistical 
significant differences with weight gain and mean blood pressure 
(p=0.001). NADPH showed the same behavior with weight gain 
(p=0.001). Also, umbilical cord H2O2 showed statistical significant 
difference with weight gain (p=0.001). Data for NF-κB was 
suggestive but missed statistical significance (p=0.053).
Table 2: Enzymatic activity in placenta and umbilical cord
Tissue and Group
Placenta Umbilical cord
A B A B
CAT (mM of H2O2/mg protein) 3227.7+3614.8 2384.6+3151.7 5371.3+5788.8 9284.4+4543.6
GPx (nmol of NADPH/mg protein)* 186.6+74.3 395.8+154.5 177.6+238.1 131.2+32.8
LPO (nmol of MAD/mg protein) 88.4+37.7 79.6+40.7 355.1+295.3 222+277.1
SOD (mM of SOD/mg protein) 3.5+4.8 3.5+6.5 2600.4+2642.6 454+514.9
A: with nutritional advise; B: without nutritional advise. CAT: catalase, GPx: glutathione peroxidase, LPO: lipoperoxidation, SOD: superoxide dismutase. 
*: p≤0.05 in placenta.
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Discussion
It is recognised that the action of maternal body composition and 
diet can influence outcomes of pregnancy and early childhood.26 In 
fact, obesity upregulates, in placenta, proinflammatory pathways and 
oxidative stress.27 The majority of these effects are mediated through 
the p38 mitogen-activated protein kinases (p38 MAPK) and NF-
κB pathways.4,28 But at present, most of the papers have published 
results from newborns or umbilical cord cells,29 underestimating 
the contribution made by maternal BMI and diet to feto-placental 
oxidative stress.30
The limitation in weight gain has been proven to protect 
against obesity related complication of pregnancy such as all types 
of hypertension, GDM and even fetal loses. In our study, it is 
interesting to note that although the group with nutritional advice 
was heavier at the beginning of pregnancy, at the end, this group had 
lower weight gain, systolic and diastolic blood pressures compared to 
the group without nutritional advice. The better metabolic control 
could explain in part a longer gestational period in the group with 
nutritional advice.
Measuring the adherence to nutritional therapy is essential to 
evaluate if outcomes are related to any given recommendations. In 
our work, we verified diet quality improvement in nine of 14 women 
submitted to the supervised nutritional program (64.2%). Several 
indexes have been proposed to assess diet quality in pregnancy and 
its effects on health outcomes18,31,32; however, the use of such indexes 
to evaluate oxidative stress in placenta is rare. This work suggests 
that NutriKcal®VO software in order to evaluate the HEI index is 
useful in pregnancy.
Given the large number of publications related to the NF-kB/
IKK complex,33 and the increasing attention of its expression in 
placenta,34-36 it is surprising the still remaining unclear explanation 
on how this complex is modulated by the mother’s diet. Most likely 
this is because the extremely difficult process to standardize and 
supervise food intake during pregnancy. In our study, the group 
with nutritional guidance showed a tendency to have higher levels 
of IKK, suggesting a beneficial effect on the inflammatory pathways 
by preventing NF-kB signaling into the nucleus. This finding 
represents a necessary, but not sufficient role of IKK in preventing 
oxidant stress effects37 as more recently, it has been shown that the 
long-standing model of cytoplasmic sequestration by IkB proteins 
is only partially true.4
Despite a lack of statistical difference in NF-κB between groups, 
there was a clear correlation with weight gain during pregnancy. 
Further work is required to define in detail the modulation of NF-
κB activity with different types of diet during pregnancy.
It has already been published that SOD is significantly decreased, 
while LPO (MDA) is increased in pre-eclamptic cases compared 
to normal pregnant women.38 Furthermore, GPx activity in pre-
eclamptic placenta has been shown to be both downregulated39 and 
upregulated.40 Notwithstanding these conflicting data, it is clear 
that improving maternal diet during pregnancy is beneficial for the 
placental and fetal antioxidant capacities.41
Taking into account the above studies, we decided to evaluate 
in placenta and umbilical cord the oxidative stress state following 
or not a gestational supervised diet. Surprisingly, neither CAT 
nor SOD was up-regulated in women without nutritional advice. 
Rather, the response was quite similar in both groups. The only 
difference that we found in this sense was with GPx, that is in 
concordance with those results reported by other authors in 
plasma,38 erythrocytes42 and placenta.40 The oxidant/antioxidant 
status formula was almost statistically significant in umbilical cord 
(p=0.52), which shows the sensitive to ROS and inflammation this 
tissue might be. Interestingly, the intra-group correlations suggest 
that the diet intervention could contribute to diminish oxidative 
stress by limiting the triglycerides increase.
Of note, multiple regression analysis showed that weight gain 
predicts oxidative stress, considering H2O2 levels activity. Adding 
this to the positive correlations between pre-pregnancy weight 
and final weight and BMI, supports the importance of controlling 
weight in benefit of the patients.
Within the limitations of this study it has been showed that 
it is possible to get improvement in the quality of diet during 
pregnancy if a nutritional supervision is offered. Taken together, 
our data indicate that nutrition counseling has a positive impact on 
the health of women with high-risk pregnancies, limiting weight 
gain as reported by others.43 Yet, another hypothesis is the putative 
beneficial effect of a quantitative and qualitative supervised mother’s 
diet, by keeping NF-κB joined to its inhibitor, thus preventing the 
effects of oxidative stress in placenta.
Conclusion
We, therefore, suggest that additional studies on the nutritional 
guidance of high-risk pregnancies are needed, to investigate the 
oxidative status modulation by different individualized interventions 
and its relation to pregnancy complications.
This study does have its limitations. First, the HMPMP is a 
high-risk pregnancy reference hospital and the conclusions may not 
be applicable to other populations. Second, despite our best efforts 
to establish a good coordination with the patients, nutritionists and 
medical staff, the number of study patients was low because mothers 
may have sought medical attention at other hospitals.
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